(688177)"Bio-Thera Solutions, Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
Filed with SSE · Stock code 688177 · · 6 pages · Chinese
Summary by 6ix AI
The meeting is scheduled to take place in November and will include both onsite and online voting options for shareholders. Shareholders must register in advance to attend the meeting and can delegate their voting rights through a proxy. The notice includes details on the voting procedures and the types of resolutions to be discussed at the meeting.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Bio-Thera Solutions, Ltd. on 6ix
Story so far
Earlier from Bio-Thera Solutions
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Obtaining the Drug Registration Certificate for BAT2306 (Secukinumab Injection)
- Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
- Announcement on Resignation of the Chief Financial Officer and Designation of the Chairman and the General Manager to Act as the Chief Financial Officer
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for Supplementary Application for Bevacizumab Injection (POBEVCY)
Later from Bio-Thera Solutions
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (688177)"Bio-Thera Solutions, Ltd."Announcement on the Latest Business Development of BAT1706 (Bevacizumab)
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Obtaining a Drug Registration Certificate for Ashuli (Golimumab Injection)
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- (688177)"Bio-Thera Solutions, Ltd."Announcement on Change of Accounting Firm
Follow Bio-Thera Solutions into a list and get an email when it puts out news.
Follow Bio-Thera Solutions